
Cuxone XL 250mg/31.25mg Injection
Marketer
Cubit Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cuxone XL 250mg/31.25mg Injection
Combiflox 250mg/31.25mg injection is a dual-action antibiotic, indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be solely under a physician's guidance. Consistent adherence to the prescribed dosage schedule is crucial; complete the full treatment course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your doctor. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician prior to commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutritious food, and sufficient hydration are recommended for optimal recovery. Your doctor might order tests to monitor the medicine's impact.
Primary Ingredients of Cuxone XL 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Cuxone XL 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cuxone XL 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cuxone XL 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cuxone XL 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Cuxone XL 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam 250mg/31.25mg (Cuxone XL Injection) combines a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Cuxone XL 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Cuxone XL, 250mg/31.25mg, is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Cuxone XL 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cuxone XL 250mg/31.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Operating a vehicle is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cuxone XL 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 250mg/31.25mg Cuxone XL Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage changes for this injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cuxone XL 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Cuxone XL 250mg/31.25mg Injection, seek medical advice from your physician.
Facts to Know About Cuxone XL 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective medications |
